ECP 2018 Final Programme

Sunday, 9 Sept 77 ECP 2018 · Bilbao Poster Presentations a Sunday PS-01 018 The prognostic value of the tumour- stroma ratio in invasive breast carcinoma W. E. Mesker, The Netherlands K. Vangangelt, L. Tollenaar, G. van Pelt, T. Dekker, P. Kuppen, R. Tollenaar 019 Adenomyoepithelioma with carcinoma of the breast: case report with next generation sequencing Phillip Williams, Canada S. Reid, A. Salehi, H. Kazerouni, S. Dhesy- Thind, C. MacColl 020 PDL1 expression in triple negative breast cancer – core needle biopsy versus lumpectomy Lukas Stifter, Austria W. Ulrich 021 High Pregnane X Receptor (PXR) expression is associated with poor prognosis in patients with invasive breast carcinoma Stamatios Theocharis, Greece C. Giaginis, S. Gourzi, G. Tsourouflis, E. Danas, L. Nakopoulou, P. Alexandrou 022 Association of serum 25-hydroxy vitamin D level and invasive breast cancer risk among Sudanese patients: a case-control study Nazik Elmalaika Husain, Sudan A. Suliman, I. Abderahman, S. Bedri, R. Musa, H. Osman, A. Mustafa, N. Jafar, E. Farah, A. Abdel Satir, A. Agaimy 023 Prognostic value of ALDH1 expression between invasive ductal carcinomas containing micropapillary components and invasive ductal carcinoma, NST Groups Yazgi Koy, Turkey U. S. Tetikkurt, A. Muhammedoglu, A. Celik 024 Positive axillary lymph node status pre-neoadjuvant chemotherapy (NACT) is associated with a high rate of post-NACT sentinel lymph node biopsy positivity Kate Dinneen, Ireland C. Quinn, D. Gibbons 025 Impact of decalcification on prognos- tic/predictive indicators in bone metastases from breast cancer. An experimental study Luca Ventura, Italy E. Di Gennaro, C. Mercurio 027 Oestrogen receptor antibodies and their performance in the UK National External Quality Assessment Scheme for Immuno- cytochemistry and In situ Hybridisation (UK NEQAS ICC & ISH) Suzanne Parry, United Kingdom A. Dodson, K. Miller 028 Clinical significance of EphA2, EphA4 and EphA7 expression in triple negative invasive breast carcinoma Stamatios Theocharis, Greece I. Nikas, K. Petsouska, C. Giaginis, P. Alexandrou, E. Danas, L. Nakopoulou, G. Tsourouflis 029 Tumour-infiltrating CD8+ lymphocytes after primary systemic therapy predict clinical outcome in patients with breast cancer Ji Won Woo, Republic of Korea Y. R. Chung, M. Kim, H. J. Kim, A. N. Seo, S. Ahn, H. Y. Na, G. Y. Choe, S. Y. Park 031 Tumour associated macrophages as potential prognostic biomarkers in breast cancer Sun-Young Kwon, Republic of Korea H.-S. Jeong, S.-H. Kang, Y.-N. Kang, M.-S. Choe, H.-R. Jung, H.-W. Lee, I.-S. Hwang, S.-P. Kim 032 Efficacy of radiotherapy after breast conserving surgery depending on the presence of tumour infiltrating lympho- cytes (TILs) Anikó Kovács, Sweden E. Werner Rönnerman, L. Hartman, M. Sjöström, D. Lundstedt, E. Holmberg, P. Malmström, M. Fernö, P. Karlsson